A Clinical trial published today has revealed a groundbreaking development for cancer treatment; that immunotherapy before surgery improves lung cancer survival.
After just two doses of immunotherapy, most patients had no residual cancer after surgery.
Professor Patrick Forde joins Pat to discuss his findings.
